Sign in

CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
863335449
Phone
919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. FWP Offering Free Writing Prospectus
  4. S-1/A Offering Registration Statement
  5. FWP Offering Free Writing Prospectus
  6. S-1/A Offering Registration Statement
  7. FWP Offering Free Writing Prospectus
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. UPLOAD Other SEC-generated Letter
  11. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  12. S-1/A Offering Registration Statement
  13. FWP Offering Free Writing Prospectus
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. FWP Offering Free Writing Prospectus
  18. S-1/A Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 12 of 13 · 259 filings